HRI Statement on Frass et al. 2020 investigation
24 October 2022HRI has been made aware of an investigation into a study published by Frass et al.1 in The Oncologist journal in 2020.
Serious allegations have been made against the research team which are strongly refuted by those involved. It is essential that the authors are given a formal ‘right of reply’ to respond to the charges made against them – something they have been denied as yet. HRI will continue to monitor this ongoing situation closely.
1. Frass M, Lechleitner P, Grundling C, Pirker C, Grasmuk-Siegl E, Domayer J, Hochmayr M, Gaertner K, Duscheck C, Muchitsch I et al (2020b) Homeopathic treatment as an add-on therapy may improve quality of life and prolong survival in patients with non-small cell lung cancer: a prospective, randomized, placebocontrolled, double-blind, three-arm, multicenter study. Oncologist 25(12):e1930-e1955